USPTO serial 79139587
Reviewed by CopyMark Law Group
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [Pharmaceutical products, namely, Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals;] Cardiovascular pharmaceuticals;[ Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; ]Pharmaceutical preparations acting on the central nervous system;[ Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases;] Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system,[ the musculo-skeletal system and the genitourinary system;] pharmaceutical preparations for use in hematology and in tissue and organ transplantation; [Pharmaceutical preparations for the treatment of eye diseases and conditions; ]Pharmaceutical preparations for the treatment of heart rhythm disorders;[ Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes;] Pharmaceutical preparations for treating hypertension;[ Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; ]Pharmaceutical products for the prevention and treatment of cancer[; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma] | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 31, 2025 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 27, 2025 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 27, 2025 | INPC | INVALIDATION PROCESSED | — |
| May 23, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 23, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 23, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 23, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 15, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Nov 11, 2023 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jun 9, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 1, 2020 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 1, 2020 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 9, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 6, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Nov 11, 2019 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 2, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 2, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 2, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 11, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 11, 2014 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 26, 2014 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 6, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 6, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 6, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 19, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 14, 2014 | ALIE | ASSIGNED TO LIE | — |
| Jun 27, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 5, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 5, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 11, 2014 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 11, 2014 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 20, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 20, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 20, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 19, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 17, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 13, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |